Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing peginterferon alfa-2b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Peginterferon alfa-2b 50micrograms injection (pdr for recon)+solvent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 80micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 100micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 150micrograms injection (pdr for recon)+solvent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 120micrograms injection (pdr for recon)+solvent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
PEG-intron redipen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
PEG-intron redipen 150micrograms powder+sterile water 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
PEG-intron redipen 120micrograms powder+sterile water 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
PEG-intron redipen 50micrograms powder+sterile water 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
PEG-intron redipen 80micrograms powder+sterile water 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 150micrograms powder+solvent for solution for injection in prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 50micrograms powder+solvent for solution for injection in prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 80micrograms powder+solvent for solution for injection in prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 100micrograms powder+solvent for solution for injection in prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 120micrograms powder+solvent for solution for injection in prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing peginterferon alfa-2b in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely peginterferon alfa-2b 150 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely peginterferon alfa-2b 80 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely peginterferon alfa-2b 120 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely peginterferon alfa-2b 50 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 100micrograms powder for solution for injection in prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely peginterferon alfa-2b 100 microgram/1 vial powder for conventional release solution for injection |
Has precise active ingredient |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely peginterferon alfa-2b 100 microgram/1 vial powder for conventional release solution for injection |
Has basis of strength substance (attribute) |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely peginterferon alfa-2b 150 microgram/1 vial powder for conventional release solution for injection |
Has basis of strength substance (attribute) |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely peginterferon alfa-2b 150 microgram/1 vial powder for conventional release solution for injection |
Has precise active ingredient |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely peginterferon alfa-2b 80 microgram/1 vial powder for conventional release solution for injection |
Has precise active ingredient |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely peginterferon alfa-2b 80 microgram/1 vial powder for conventional release solution for injection |
Has basis of strength substance (attribute) |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely peginterferon alfa-2b 50 microgram/1 vial powder for conventional release solution for injection |
Has precise active ingredient |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely peginterferon alfa-2b 50 microgram/1 vial powder for conventional release solution for injection |
Has basis of strength substance (attribute) |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely peginterferon alfa-2b 120 microgram/1 vial powder for conventional release solution for injection |
Has precise active ingredient |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely peginterferon alfa-2b 120 microgram/1 vial powder for conventional release solution for injection |
Has basis of strength substance (attribute) |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Peginterferon alfa-2b only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only peginterferon alfa-2b in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely peginterferon alfa-2b 150 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely peginterferon alfa-2b 150 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely peginterferon alfa-2b 120 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely peginterferon alfa-2b 120 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely peginterferon alfa-2b 80 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely peginterferon alfa-2b 80 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely peginterferon alfa-2b 50 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely peginterferon alfa-2b 50 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
False |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial |
Has precise active ingredient |
True |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection vial |
Has precise active ingredient |
True |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen |
Has precise active ingredient |
True |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen |
Has precise active ingredient |
True |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen |
Has precise active ingredient |
True |
Peginterferon alfa-2b |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |